Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 2,301 | 2,297 | 2,133 | 1,770 | 2,435 |
| Gross Profit | 2,301 | 2,297 | 2,133 | 1,770 | 2,435 |
| Operating Expenses | 6,543 | 6,593 | 7,629 | 10,475 | 11,209 |
| Operating Income | -4,242 | -4,296 | -5,496 | -8,705 | -8,774 |
| Other Income | 15 | 8 | 9 | 17 | 46 |
| Pre-tax Income | -4,227 | -4,288 | -5,487 | -8,688 | -8,728 |
| Net Income Continuous | -4,227 | -4,288 | -5,487 | -8,688 | -8,728 |
| Net Income | $-4,227 | $-4,288 | $-5,487 | $-8,688 | $-8,728 |
| EPS Basic Total Ops | -0.11 | -0.11 | -0.14 | -0.23 | -0.23 |
| EPS Basic Continuous Ops | -0.11 | -0.11 | -0.14 | -0.23 | -0.23 |
| EPS Diluted Total Ops | -0.11 | -0.11 | -0.14 | -0.23 | -0.23 |
| EPS Diluted Continuous Ops | -0.11 | -0.11 | -0.14 | -0.23 | -0.23 |
| EBITDA(a) | $-4,141 | $-4,158 | $-5,322 | $-8,001 | $-8,555 |